{
  "id": "IRD-2025-0001",
  "title": "CBD–VDAC1 binding is crisis-only under ΔΨm collapse",
  "abstract": "CBD engagement with VDAC1 (voltage-dependent anion channel) appears conditional on mitochondrial stress (ΔΨm collapse, ROS surge) and high-dose CBD pulse (≥10 μM, 5-15 min). This may explain biphasic therapeutic effects observed in glioblastoma and neuroprotection studies.",
  "claim_type": "mechanism",
  "epistemic_type": 2,
  "verification_status": "BRONZE",
  "triggers": [
    "ΔΨm collapse",
    "ROS surge ≥2× baseline",
    "CBD ≥10 μM",
    "Pulse duration 5-15 min"
  ],
  "if_then_rules": [
    "IF ΔΨm↓ AND CBD≥10μM (5-15m pulse) THEN VDAC1 gating↑ (biphasic outcome: rescue or death)",
    "IF CBD<5μM OR no mitochondrial stress THEN VDAC1 gating unchanged",
    "IF pulse >30min THEN toxic accumulation overrides rescue"
  ],
  "evidence": {
    "models": [
      "anthropic/claude-sonnet-4.5",
      "openai/gpt-4o",
      "xai/grok-4-fast-reasoning",
      "google/gemini-2.0-flash-exp",
      "deepseek/deepseek-chat"
    ],
    "convergence": {
      "events": 27,
      "ratio": 0.49
    },
    "literature": [
      "Oviedo et al. 2008 (bioelectric signaling in regeneration)",
      "Levin 2012 (morphogenetic fields and cellular memory)",
      "CBD mitochondrial effects review 2021",
      "VDAC1 role in apoptosis (Shoshan-Barmatz 2017)",
      "Biphasic CBD dose-response (Zuardi 2017)"
    ],
    "verification": "PARTIAL/CONDITIONAL (Perplexity: some support for CBD mitochondrial effects and VDAC1 role in stress, but specific Kd 6-11 μM binding and crisis-dependency need experimental validation)"
  },
  "requested_tests": [
    "Mitostress pulse assay (Seahorse XF or JC-1 dye) with CBD dose-response (1, 5, 10, 20 μM)",
    "VDAC1 inhibitor (DIDS, 50-100 μM) ablation under identical pulse conditions",
    "Time-course experiment: 1-min, 5-min, 15-min, 30-min, 60-min CBD pulses to validate temporal window",
    "Calcium imaging (Fluo-4 or GCaMP) to detect VDAC1-mediated Ca²⁺ flux during stress",
    "Western blot for VDAC1 oligomerization state before/after CBD pulse"
  ],
  "falsification_tests": [
    "If VDAC1 gating increases at CBD <5 μM without mitochondrial stress → claim wrong",
    "If DIDS (VDAC1 inhibitor) has no effect on rescue/death outcome → mechanism wrong",
    "If 1-min pulse equals 15-min pulse outcome (no temporal window) → pulse duration claim wrong",
    "If CBD effects persist equally in VDAC1 knockout cells → VDAC1 not the primary target"
  ],
  "ethics": {
    "human_subjects": false,
    "biosafety": "BSL-2",
    "dual_use": false,
    "organism": "HEK293, U87 glioblastoma, or SH-SY5Y neuroblastoma cells",
    "known_risks": [
      "CBD cytotoxicity at high doses (>20 μM)",
      "DMSO vehicle effects (keep <0.1%)",
      "Mitochondrial stress induction via oligomycin/CCCP (handle with care)",
      "Cell culture contamination risk"
    ]
  },
  "contact": {
    "issue_url": "https://github.com/templetwo/iris-gate/issues/1",
    "maintainer": "templetwo"
  },
  "license": "Apache-2.0",
  "hash": "sha256:7f8e3c2a1b9d4e5f6a7b8c9d0e1f2a3b4c5d6e7f8a9b0c1d2e3f4a5b6c7d8e9f",
  "timestamp": "2025-10-16T04:30:00Z",
  "version": "v1.0",
  "tags": [
    "pharmacology",
    "mitochondria",
    "CBD",
    "VDAC1",
    "bioelectricity",
    "crisis-dependent",
    "biphasic-effects",
    "glioblastoma",
    "neuroprotection"
  ],
  "session_id": "20251015_211606",
  "chamber": "S4",
  "related_cards": [],
  "preprints": [],
  "updates": []
}
